Search Results - jochen+prehn

2 Results

Sort By:

A new method for the treatment of colorectal cancer (CRC) Inhibitors of the proteasomal component, Rpt4

Introduction Colorectal cancer (CRC) is one of the most common forms of cancer in both males and females and a leading cause of cancer related deaths. Industry analysis estimates that the colorectal cancer market was valued at $6 billion in 2009 with a projected CAGR of 9.8% and projected market value of approximately $12 billion by 2016. This...

Published: 5/23/2011 | Inventor(s): Jochen Prehn

Keywords(s):

Category(s): Cancer

Therapeutic Opportuitues: ALS & Neuro-degenerative Diseases

Introduction Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease in the US, is the most common neurodegenerative disorder of young and middle aged adults that is incurable and invariably fatal. The only disease-modifying therapy currently available is Riluzole®, which only extends survival by 3-6 months and has recently come...

Published: 2/8/2011 | Inventor(s): Jochen Prehn, Orla Hardiman, Matt Greenway, Dairin Kieran

Keywords(s): Prehn

Category(s): Regenerative Medicine